カテゴリー： 世界, 医療/バイオ, Grand View Research

包括的代謝パネル検査のグローバル市場2023-2030：K+、Na+、Cl-、CO2、グルコース

【英語タイトル】Comprehensive Metabolic Panel Testing Market Size, Share & Trends Analysis Report By Analytes (K+, Na+, Cl-, CO2, Glucose), By Disease, By End-use (Laboratory, PoC), By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NVB034）・商品コード：GRV23NVB034
・発行会社（調査会社）：Grand View Research
・発行日：2023年10月4日
・ページ数：100
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：臨床診断
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

包括的代謝パネル検査市場の成長と動向
Grand View Research社の最新レポートによると、包括的代謝パネル検査の世界市場規模は2030年までに208億7000万米ドルに達する見込みです。同市場は2023年から2030年にかけて年平均成長率9.1%で拡大する見込みです。世界的な疾病負担の増加と新規診断製品の出現が市場を牽引しています。

慢性疾患の有病率の上昇と医療費抑制ニーズの高まりが、疾患の早期診断と定期的なモニタリングの需要を高め、CMP検査市場を押し上げる見通しです。バイオチップ、マイクロアレイ、コンパニオン診断薬など、技術的に進歩した製品の導入により、異常の早期発見の必要性が高まっています。CMP検査は、いくつかの疾患の同定、診断、モニタリングのために、14の分析物を評価する費用対効果と時間の節約になる方法を提供します。

医療に対する消費者の意識の高まりは、CMP検査市場を牽引すると予想される主な要因の1つです。世界中の多くの組織が、疾患、利用可能な治療オプション、早期診断と予防措置の利点に関する認知度向上に取り組んでいます。例えば、国際糖尿病財団（International Diabetes Foundation）や米国糖尿病協会（American Diabetes Association）は、複数の啓発キャンペーンやその他の広告手段を通じて、糖尿病の診断とモニタリングの緊急の必要性を強調している主要団体の一部です。

包括的代謝パネル検査市場では、製品価格に微妙な違いがあるため、消費者の購買行動は中程度に複雑です。さまざまな市場プレーヤーが提供する製品は、競争上のライバル関係を高めるために戦略的な価格設定になっています。市場の競争が激化するにつれて、安全性、有効性、感度、特異度といった診断法の改善に対する消費者のニーズはかつてないほど高まると予想されます。

医療診断の状況は、改良型診断薬の発売やバイオマーカーの導入により、ここ数年でパラダイムシフトが起きています。しかし、再発や疾患の進行は、特に高齢者において依然として高い水準にあります。強いアンメットニーズは、CMP検査分野において画期的なファースト・イン・クラスの診断薬を開発する重要な機会となっています。

包括的代謝パネル検査市場レポートハイライト

- 腎臓病セグメントは2022年に32.71%の最大売上シェアを占め、このセグメントは高い疾患有病率と分析物の最大利用率に牽引されています。

- 糖尿病セグメントは予測期間中、CAGR 9.9%の最速成長が見込まれます。糖尿病患者の50％近くが未診断のままであり、総合的な代謝パネル検査市場に有望な成長機会をもたらしています。

- PoCセグメントは予測期間中、最も速いCAGR 9.8%で成長する見込みです。PoCによるCMP検査は、操作の簡便性、携帯性、結果の迅速性、サンプルの必要性の低さが原動力となっています。

- 検査室セグメントは、入手のしやすさ、市場への浸透度の高さ、使用量の増加、臨床的に重要な結果が原動力となり、2022年に59.97%の最高売上シェアを占めました。

- アジア太平洋地域は、医療インフラの改善、慢性疾患にかかりやすい高齢者の増加、消費者の意識の高まり、可処分所得の増加、全体的な経済発展に牽引され、予測期間中11.7%のCAGRで最も高い成長が見込まれています。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. 包括的代謝パネル検査市場変数・傾向・範囲
第4章. 包括的代謝パネル検査の世界市場：分析対象物別予測・傾向分析
第5章. 包括的代謝パネル検査の世界市場：疾患別予測・傾向分析
第6章. 包括的代謝パネル検査の世界市場：エンドユース別予測・傾向分析
第7章. 包括的代謝パネル検査の世界市場：地域別予測・傾向分析
第8章. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Analytes
1.1.2. Disease
1.1.3. End use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Analytes outlook
2.2.2. Disease outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Comprehensive Metabolic Panel Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Comprehensive Metabolic Panel Testing Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Comprehensive Metabolic Panel Testing Market: Analytes Estimates & Trend Analysis
4.1. Comprehensive Metabolic Panel Testing Market: Key Takeaways
4.2. Comprehensive Metabolic Panel Testing Market: Movement & Market Share Analysis, 2022 & 2030
4.3. K+
4.3.1. K+ market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Na+
4.4.1. Na+ market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Cl-
4.5.1. Cl- market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. CO2
4.6.1. CO2 market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Glucose
4.7.1. Glucose market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. BUN
4.8.1. BUN market estimates and forecasts, 2018 to 2030 (USD Million)
4.9. Creatinine
4.9.1. Creatinine market estimates and forecasts, 2018 to 2030 (USD Million)
4.10. Ca++
4.10.1. Ca++ market estimates and forecasts, 2018 to 2030 (USD Million)
4.11. Albumin
4.11.1. Albumin market estimates and forecasts, 2018 to 2030 (USD Million)
4.12. Total Protein
4.12.1. Total protein market estimates and forecasts, 2018 to 2030 (USD Million)
4.13. ALP
4.13.1. ALP market estimates and forecasts, 2018 to 2030 (USD Million)
4.14. ALT
4.14.1. ALT market estimates and forecasts, 2018 to 2030 (USD Million)
4.15. AST
4.15.1. AST market estimates and forecasts, 2018 to 2030 (USD Million)
4.16. Total Bilirubin
4.16.1. Total bilirubin market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Comprehensive Metabolic Panel Testing Market: Disease Estimates & Trend Analysis
5.1. Comprehensive Metabolic Panel Testing Market: Key Takeaways
5.2. Comprehensive Metabolic Panel Testing Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Kidney Diseases
5.3.1. Kidney diseases market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Liver Diseases
5.4.1. Liver diseases market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Diabetes
5.5.1. Diabetes market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Comprehensive Metabolic Panel Testing Market: End-Use Estimates & Trend Analysis
6.1. Comprehensive Metabolic Panel Testing Market: Key Takeaways
6.2. Comprehensive Metabolic Panel Testing Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Laboratories
6.3.1. Laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.2. Emergency departments
6.3.2.1. Emergency departments market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.3. Hospital wards
6.3.3.1. Hospital wards market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.4. Primary care
6.3.4.1. Primary care market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.5. Pharmacy
6.3.5.1. Pharmacy market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.6. Telemedicine
6.3.6.1. Telemedicine market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. PoC
6.4.1. PoC market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.2. Emergency departments
6.4.2.1. Emergency departments market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.3. Hospital wards
6.4.3.1. Hospital wards market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.4. Primary care
6.4.4.1. Primary care market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.5. Pharmacy
6.4.5.1. Pharmacy market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.6. Telemedicine
6.4.6.1. Telemedicine market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. PoC (Instruments)
6.5.1. PoC market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.2. Piccolo Xpress
6.5.2.1. Piccolo xpress market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.3. Skyla-HB1
6.5.3.1. Skyla-HB1 market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.4. DRI-CHEM NX500
6.5.4.1. DRI-CHEM NX500 market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.5. Others
6.5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Comprehensive Metabolic Panel Testing Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Comprehensive Metabolic Panel Testing Market by Region: Key Marketplace Takeaway
7.3. North America
7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.6. Denmark
7.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.7. Sweden
7.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.8. Norway
7.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
8.2.1. Abbott
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Quest Diagnostics
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Laboratory Corporation of America Holdings
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Sonic Healthcare Limited
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Unipath
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. SYNLAB International GmbH
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. ARUP Laboratories
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Genoptix Inc.
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Nova Biomedical
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives

List of Tables

Table 1 List of abbreviation
Table 2 North America comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 3 North America comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 4 North America comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 5 North America comprehensive metabolic panel testing market, by region, 2018 - 2030 (USD Million)
Table 6 U.S. comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 7 U.S. comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 8 U.S. comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 9 Canada comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 10 Canada comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 11 Canada comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 12 Europe comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 13 Europe comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 14 Europe comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 15 Europe comprehensive metabolic panel testing market, by region, 2018 - 2030 (USD Million)
Table 16 Germany comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 17 Germany comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 18 Germany comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 19 UK comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 20 UK comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 21 UK comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 22 France comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 23 France comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 24 France comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 25 Italy comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 26 Italy comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 27 Italy comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 28 Spain comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 29 Spain comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 30 Spain comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 31 Denmark comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 32 Denmark comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 33 Denmark comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 34 Sweden comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 35 Sweden comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 36 Sweden comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 37 Norway comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 38 Norway comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 39 Norway comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 40 Asia Pacific comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 41 Asia Pacific comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 42 Asia Pacific comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 43 Asia Pacific comprehensive metabolic panel testing market, by region, 2018 - 2030 (USD Million)
Table 44 Japan comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 45 Japan comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 46 Japan comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 47 China comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 48 China comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 49 China comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 50 India comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 51 India comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 52 India comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 53 Australia comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 54 Australia comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 55 Australia comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 56 Thailand comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 57 Thailand comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 58 Thailand comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 59 South Korea comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 60 South Korea comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 61 South Korea comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 62 Latin America comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 63 Latin America comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 64 Latin America comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 65 Latin America comprehensive metabolic panel testing market, by region, 2018 - 2030 (USD Million)
Table 66 Brazil comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 67 Brazil comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 68 Brazil comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 69 Mexico comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 70 Mexico comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 71 Mexico comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 72 Argentina comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 73 Argentina comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 74 Argentina comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa comprehensive metabolic panel testing market, by region, 2018 - 2030 (USD Million)
Table 79 South Africa comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 80 South Africa comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 81 South Africa comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 85 UAE comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 86 UAE comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 87 UAE comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)
Table 88 Kuwait comprehensive metabolic panel testing market, by analytes, 2018 - 2030 (USD Million)
Table 89 Kuwait comprehensive metabolic panel testing market, by disease, 2018 - 2030 (USD Million)
Table 90 Kuwait comprehensive metabolic panel testing market, by end use, 2018 - 2030 (USD Million)

★調査レポート[包括的代謝パネル検査のグローバル市場2023-2030：K+、Na+、Cl-、CO2、グルコース] (コード：GRV23NVB034)販売に関する免責事項を必ずご確認ください。
★調査レポート[包括的代謝パネル検査のグローバル市場2023-2030：K+、Na+、Cl-、CO2、グルコース]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 包括的代謝パネル（CMP）検査のグローバル市場（2023年-2030年）：グルコース、カルシウム、電解質、腎機能検査、肝機能検査、タンパク質
  • グルコース・デキストロース・マルトデキストリンの世界市場：市場シェア・需要予測2024-2030
  • 世界の血液検査市場2022-2032：検査種類別（グルコース、A1C、ダイレクトLDL、脂質パネル、前立腺特異抗原、新型コロナウイルス感染症、血中尿素窒素（BUN）検査、ビタミンD、テストステロン、ALT、クレアチニン、その他）、地域別
  • 世界の毛細血管採血装置市場2023-2030：素材別（プラスチック、ガラス、ステンレス、セラミック、その他）、製品別、エンドユーザー別、用途別、地域別
  • 世界のウェアラブルヘルスケアデバイス市場（～2028年）：製品別（トラッカー、スマートウォッチ、パッチ）、種類別（診断用（バイタルサイン、心電図、グルコース）、治療用（疼痛、インスリン））、グレード別（消費者用、臨床用）、チャネル別（オンライン、薬局）、用途別（RPM）
  • CMF（クロロメチルフルフラール）の世界市場2023-2029：糖類、グルコース
  • 世界のレジオネラ菌検査市場（2023-2030）：種類別（水質検査、IVD検査）、エンドユーザー別（微生物培養、直接蛍光抗体（DFA）染色、PCR、その他）、地域別
  • 世界のベッドヘッドパネル市場2024-2030：専門分野別（ICU、外科）、エンドユーザー別（病院、クリニック）、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ）
  • 世界の腸疾患検査市場2023-2030：疾患種類別（細菌性腸疾患、ウイルス性腸疾患、寄生性腸疾患）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆